Government Trades

Overview
Securities
Members
States
Chambers
Committees
Parties

Chugai Pharmaceutical Co Ltd

(OTC:CHGCY)
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

top performing CHGCY trades

Josh Gottheimer headshot
Josh Gottheimer
House (D-NJ)
40.90%
Daniel Goldman headshot
Daniel Goldman
House (D-NY)
-2.30%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Chugai Pharmaceutical trades made by congress members.
Josh GottheimerHouse (D-NJ)
$1K - $15KSale (Partial)Jul 09, 2024Jun 21, 2024
House
Josh GottheimerHouse (D-NJ)
$1K - $15KSale (Partial)May 15, 2024Apr 04, 2024
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockPurchaseSep 16, 2023Aug 18, 2023
House
Daniel GoldmanHouse (D-NY)
$1K - $15KstockSaleAug 13, 2023Jul 10, 2023
House
Daniel GoldmanHouse (D-NY)
$15K - $50KstockSaleApr 17, 2023Mar 31, 2023
House
Daniel GoldmanHouse (D-NY)
$1K - $15KstockPurchaseMar 20, 2023Feb 27, 2023
House